BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -291.41% | 89.56% | 9.04% | -318.93% | 39.40% |
| Total Depreciation and Amortization | -1.68% | 76.73% | -6.48% | -0.46% | 3.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 162.04% | -118.35% | 22.50% | 2,039.01% | -537.25% |
| Change in Net Operating Assets | -106.98% | 169.35% | -65.89% | -140.51% | 356.25% |
| Cash from Operations | -83.61% | 39.29% | 47.29% | -200.90% | 65.43% |
| Capital Expenditure | 70.02% | -669.37% | 23.71% | 33.86% | -19.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.78% | -- | -- | -- | -- |
| Cash from Investing | 75.58% | -770.72% | 23.71% | 33.86% | -19.89% |
| Total Debt Issued | -- | -- | -- | 455.48% | -71.22% |
| Total Debt Repaid | -37.82% | 7.75% | -43.33% | 5.26% | 1.04% |
| Issuance of Common Stock | -100.00% | 36,246.15% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.56% | 4,070.69% | -101.66% | 492.48% | -75.08% |
| Foreign Exchange rate Adjustments | -129.41% | 666.67% | -104.17% | 7,300.00% | -110.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -238.57% | 190.26% | -150.55% | 1,600.40% | -116.73% |
